318 related articles for article (PubMed ID: 32892991)
1. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.
Salah HM; Naser JA; Calcaterra G; Bassareo PP; Mehta JL
Am J Cardiol; 2020 Nov; 134():155-157. PubMed ID: 32892991
[No Abstract] [Full Text] [Related]
2. 2020 - Year of COVID-19.
Lillicrap D; Morrissey JH
J Thromb Haemost; 2020 Sep; 18(9):2081. PubMed ID: 32881334
[No Abstract] [Full Text] [Related]
3. Anticoagulation in COVID-19: DDI Perspective.
Khiali S; Entezari-Maleki T
Clin Appl Thromb Hemost; 2020; 26():1076029620959457. PubMed ID: 32936672
[No Abstract] [Full Text] [Related]
4. ISTH DIC subcommittee communication on anticoagulation in COVID-19.
Thachil J; Juffermans NP; Ranucci M; Connors JM; Warkentin TE; Ortel TL; Levi M; Iba T; Levy JH
J Thromb Haemost; 2020 Sep; 18(9):2138-2144. PubMed ID: 32881336
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 coagulopathy: an evolving story.
The Lancet Haematology
Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
[No Abstract] [Full Text] [Related]
6. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.
Wanderer JP; Nathan N
Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849
[No Abstract] [Full Text] [Related]
7. Meta-Analysis of Relation of Creatine kinase-MB to Risk of Mortality in Coronavirus Disease 2019 Patients.
Shi L; Wang Y; Wang Y; Duan G; Yang H
Am J Cardiol; 2020 Sep; 130():163-165. PubMed ID: 32622501
[No Abstract] [Full Text] [Related]
8. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
Guo X; Zhu Y; Hong Y
Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
[No Abstract] [Full Text] [Related]
9. Lessons from the Italian COVID-19 frontline.
Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
[No Abstract] [Full Text] [Related]
10. Cobrotoxin could be an effective therapeutic for COVID-19.
Lin F; Reid PF; Qin ZH
Acta Pharmacol Sin; 2020 Sep; 41(9):1258-1260. PubMed ID: 32843715
[No Abstract] [Full Text] [Related]
11. COVID-19 and Hypercoagulability.
Sholzberg M
Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
[No Abstract] [Full Text] [Related]
12. Anticoagulation in Hospitalized Patients with Covid-19.
Chowdhury JF; Moores LK; Connors JM
N Engl J Med; 2020 Oct; 383(17):1675-1678. PubMed ID: 33085867
[No Abstract] [Full Text] [Related]
13. Coagulation abnormalities and thrombosis in patients with COVID-19.
Levi M; Thachil J; Iba T; Levy JH
Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
[No Abstract] [Full Text] [Related]
14. Case Fatality Rate of COVID-19: Meta-Analysis Approach.
Almasi-Hashiani A; Doosti-Irani A; Mansournia MA
Arch Iran Med; 2020 Sep; 23(9):644-646. PubMed ID: 32979914
[No Abstract] [Full Text] [Related]
15. Current Perspectives of Anticoagulation in Patients With COVID-19.
Gavioli EM; Sikorska G; Man A; Rana J; Vider E
J Cardiovasc Pharmacol; 2020 Aug; 76(2):146-150. PubMed ID: 32569013
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 update: Covid-19-associated coagulopathy.
Becker RC
J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
[No Abstract] [Full Text] [Related]
17. A concern about survival time as an endpoint in coronavirus disease 2019 clinical trials.
Tan KS
Clin Trials; 2020 Oct; 17(5):505-506. PubMed ID: 32815389
[No Abstract] [Full Text] [Related]
18. Are statins safe in patients with COVID-19?
Karalis DG
J Clin Lipidol; 2020; 14(4):396-397. PubMed ID: 32682805
[No Abstract] [Full Text] [Related]
19. Severe COVID-19 infection associated with endothelial activation.
Escher R; Breakey N; Lämmle B
Thromb Res; 2020 Jun; 190():62. PubMed ID: 32305740
[No Abstract] [Full Text] [Related]
20. COVID-19 and venous thromboembolism: current insights and prophylactic strategies.
Ambrosino P; Di Minno A; Maniscalco M; Di Minno MND
Ann Med; 2020 Sep; 52(6):239-242. PubMed ID: 32619360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
